MCRPC

Clinical trials for MCRPC explained in plain language.

Never miss a new study

Get alerted when new MCRPC trials appear

Sign up with your email to follow new studies for MCRPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 3 Completed 1

Experimental cell therapy aims to boost immune system against Hard-to-Treat prostate cancer

Disease control Completed

This early-phase trial tested an experimental cell therapy called INKmune in 12 men with advanced prostate cancer that no longer responds to hormone therapy. The goal was to find the safest and most effective dose by measuring immune cell activity, PSA levels, and tumor changes. …

Matched conditions: MCRPC

Phase: PHASE1, PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:09 UTC

MCRPC

Get alerted when new MCRPC trials appear

Experimental cell therapy aims to boost immune system against Hard-to-Treat prostate cancer